Letter to the Editor From Cosentini et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival"
- PMID: 35302612
- DOI: 10.1210/clinem/dgac169
Letter to the Editor From Cosentini et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival"
Comment in
-
Response to Letter to the Editor From Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival".J Clin Endocrinol Metab. 2022 Jun 16;107(7):e3101-e3102. doi: 10.1210/clinem/dgac170. J Clin Endocrinol Metab. 2022. PMID: 35302610 Free PMC article. No abstract available.
Comment on
-
Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival.J Clin Endocrinol Metab. 2022 Mar 24;107(4):964-971. doi: 10.1210/clinem/dgab865. J Clin Endocrinol Metab. 2022. PMID: 34850915 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical